Errik Anderson
SelectiveNamed in filings at 82vsOn the current fund
- Board seats filed
- 12
all filings on record
Named in filings at 82vsOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Human Biotech | Biotech & pharma | May 2026 | None on file |
| Angiex | Biotech & pharma | July 2025 | Presight Capital |
| Aakha Biologics | Biotech & pharma | July 2024 | None on file |
| Alumni Ventures Group | Not yet classified | April 2024 | Acrew Capital, Bolster Ventures |
| Cantai Therapeutics | Biotech & pharma | November 2023 | None on file |
| Mytide Therapeutics | Biotech & pharma | December 2021 | None on file |
| Wheeler Bio | Biotech & pharma | November 2021 | None on file |
| Vernal Biosciences | Biotech & pharma | April 2021 | None on file |
| Alloy Therapeutics | Biotech & pharma | March 2021 | MC Healthcare Ventures, Presight Capital |
| Compass Therapeutics | Biotech & pharma | May 2014 | 270 Healthcare Growth, Borealis |
| Avitide | Biotech & pharma | May 2014 | Borealis, Omega Funds, Sands Capital Ventures, SV Life Sciences |
| Arsanis | Biotech & pharma | July 2013 | Drover Ventures, Omega Funds, Polaris Partners, SV Life Sciences |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The category is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Categories of companies where filings name Errik Anderson on the board, based on 11 filed seats with a verified or cited source.
1 more filed seat not yet classified, left out of the shares above.